IA
DPLO

IFP Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

IFP Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,231
Closed -$25K – 4161
2018
Q1 		$25K Hold
1,231
– – ﹤0.01% 2262
2017
Q4 		$25K Sell
1,231
-1,700
-58% -$33.4K ﹤0.01% 2293
2017
Q3 		$61K Sell
2,931
-420
-13% -$7.1K ﹤0.01% 1877
2017
Q2 		$50K Buy
3,351
+131
+4% +$2.18K ﹤0.01% 1981
2017
Q1 		$51K Buy
3,220
+670
+26% +$9.66K ﹤0.01% 1918
2016
Q4 		$32K Buy
2,550
+1,657
+186% +$30.9K ﹤0.01% 2163
2016
Q3 		$25K Buy
893
+663
+288% +$22.2K ﹤0.01% 2282
2016
Q2 		$8K Buy
+230
New +$7.23K ﹤0.01% 2900
2016
Q1 		– Sell
-305
Closed -$10K – 3785
2015
Q4 		$10K Buy
+305
New +$9.52K ﹤0.01% 2605

Other funds holding DPLO

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

IFP Advisors's DPLO Position: Q2 2018 in Review

IFP Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 1,231 shares — an estimated $25K sold.

IFP Advisors first reported a position in DPLO in Q4 2015 and held it in 9 quarters. The position peaked at $61K in Q3 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • IFP Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
  • IFP Advisors sold 1,231 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $25K.
  • IFP Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 9 quarters.
  • IFP Advisors's DIPLOMAT PHARMACY, INC. position peaked at $61K in Q3 2017.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.